Frontier Science Foundation Welcomes Marlene Smurzynski, PhD, MSPH
Frontier Science Foundation welcomes Marlene Smurzynski, PhD, MSPH, as our new Executive Director. Marlene joins our Frontier Science Leadership Group with an initial focus on assisting with business development efforts and other infrastructure needs. Marlene brings with her vast experience and knowledge gained from working in the private and public sector. Following receipt of her doctorate in Epidemiology from UNC Gilling’s School of Global Public Health, she joined the Harvard T.H. Chan School of Public Health as a research scientist working with the AIDS Clinical Trials Group. Following her work at Harvard, Marlene launched and thereafter directed a new division in observational research at a large CRO.
Marlene has held positions in scientific and business development, focusing primarily on pharmacoepidemiology and observational studies, while overseeing contracts, operations, managing client expectations and project start-up. With more than two decades of experience in leading and conducting innovative scientific research, Marlene will be a key contributor to the strategic and business development operations of Frontier Science.
Sue Siminski, Frontier Science’s CEO, “We were looking for- and were excited to find- someone with experience in the business aspects of clinical research in addition to the practical and scientific aspects. This is an unusual blend of skills that is not easy to find. With Marlene and her new role, we will have a trusted leader and advisor for our business development plans as we steer the organization towards an advanced technological future. We are all looking forward to Marlene’s contributions in helping us accomplish our strategic goals and furthering our scientific agenda.”
“I am excited to be working with such an esteemed and accomplished group of individuals here at Frontier Science! I look forward to contributing to the continued growth and ongoing exceptional scientific work in progress.” ~ Marlene Smurzynski